The following meeting highlights are from the Perspectives in Melanoma XII conference, held in Scheveningen/The Hague, the Netherlands, on October 2-4, 2008. Selected reviews are included but further discussions of these and other presentations are posted at http://www.MelanomaCare.org.

Additional Metadata
Keywords agatolimod, alpha interferon, alpha2b interferon, anthracycline, antineoplastic agent, as 15, aso 2b, bms 663513, cancer antibody, carboplatin, cd40 antibody agonist, cp 870893, cytokine, cytotoxic T lymphocyte antigen 4 antibody, dacarbazine, granulocyte macrophage colony stimulating factor, immunoglobulin G antibody, ipilimumab, mdx 1106, melanoma antigen 3, monoclonal antibody, paclitaxel, peginterferon, protein Nodal, serum amyloid A, sorafenib, temozolomide, ticilimumab, toll like receptor agonist, unclassified drug
Persistent URL dx.doi.org/10.1111/j.1755-148X.2009.00555.x, hdl.handle.net/1765/18029
Journal Pigment Cell & Melanoma Research
Citation
Kirkwood, J.M, & Eggermont, A.M.M. (2009). Highlights from the perspectives in melanoma XII conference. Pigment Cell & Melanoma Research, 22(2), 156–165. doi:10.1111/j.1755-148X.2009.00555.x